Turn Medical, LLC Company Profile

Background

Turn Medical, LLC, established in 2018 and headquartered in San Antonio, Texas, is a medical device company dedicated to enhancing patient outcomes and caregiver safety through innovative solutions. The company's flagship product, the Pronova-O₂™ Automated Prone Therapy System, addresses the challenges associated with prone positioning in critically ill patients, particularly those with respiratory distress. By automating this labor-intensive process, Turn Medical aims to improve patient comfort, reduce caregiver injury risks, and decrease overall healthcare costs.

Key Strategic Focus

Turn Medical's strategic focus centers on the development and commercialization of automated medical devices that streamline critical care procedures. The Pronova-O₂™ system exemplifies this focus by offering three therapy modes: prone therapy, prone therapy with continuous lateral rotation, and supine continuous lateral rotation. These modes facilitate efficient patient positioning, which is crucial for improving respiratory function in critically ill patients. The system's design emphasizes user-friendliness, incorporating an intuitive interface developed with input from critical care nurses, and features an ergonomic design suitable for a wide range of patients.

Financials and Funding

As of February 2022, Turn Medical secured a $3.8 million bridge financing round to support the ongoing commercialization of the Pronova-O₂™ system. This funding is intended to enhance the company's ability to meet the growing demand for automated prone therapy solutions in hospitals and critical care units.

Pipeline Development

Currently, Turn Medical's primary focus is on the Pronova-O₂™ Automated Prone Therapy System. The company has not publicly disclosed additional pipeline candidates or specific timelines for future product developments.

Technological Platform and Innovation

Turn Medical's innovation is embodied in the Pronova-O₂™ system, which automates the prone positioning process for critically ill patients. This system is designed to improve patient outcomes by facilitating early prone positioning, a practice that has been shown to reduce mortality in patients with respiratory distress. The system's automation also aims to alleviate the physical strain on healthcare providers, thereby enhancing caregiver safety.

Leadership Team

The leadership team at Turn Medical includes:

• Tara Psencik, BSN RN: Chief Executive Officer and Chief Clinical Officer.

• Chris Neiderkrom: Chief Operating Officer.

• Neil Kellen: Chief Financial Officer.

• Steve Kahn: Chief Regulatory Officer.

• Carlos Trevino: Director of Sales.

• John Mills: Director of Marketing.

Each member brings a wealth of experience in healthcare and medical device sectors, contributing to the company's mission of delivering impactful patient care solutions.

Market Insights and Dynamics

The medical device industry, particularly in the realm of critical care solutions, is experiencing significant growth. The increasing prevalence of respiratory illnesses and the need for efficient patient care are driving demand for innovative solutions like automated prone therapy systems. This market is characterized by rapid technological advancements and a focus on improving patient outcomes while reducing healthcare costs.

Competitor Analysis

Turn Medical operates in a competitive landscape that includes companies such as Enable Injections, Berlinger, Heathrow Scientific, and bNovate Technologies. These competitors offer a range of medical devices and solutions, each with unique technologies and market approaches. However, Turn Medical's specialized focus on automated prone therapy positions it uniquely within this space.

Strategic Collaborations and Partnerships

In January 2023, Turn Medical partnered with US Med-Equip to provide hospitals with on-demand access to the Pronova-O₂™ Automated Prone Therapy System. This collaboration aims to enhance the availability and utilization of the system in critical care settings.

Operational Insights

Turn Medical's strategic considerations include expanding its market presence through partnerships and collaborations, enhancing product offerings, and addressing the evolving needs of healthcare providers. The company's focus on automation and caregiver safety differentiates it from competitors, providing a distinct competitive advantage in the critical care medical device market.

Strategic Opportunities and Future Directions

Looking ahead, Turn Medical aims to leverage its innovative technology to expand its product portfolio and market reach. The company is well-positioned to capitalize on the growing demand for automated medical devices that improve patient outcomes and caregiver safety. Future directions may include the development of additional products that address other critical care challenges, further solidifying Turn Medical's role as a leader in healthcare innovation.